Medicsight Inc.'s (AMEX: MGT) majority owned subsidiary, Medicexchange announced today that it has appointed Mr. Mercury Liu, Mr. Benny Xu and Mr. Timothy Huang as its Regional Sales Managers. The new team will be in charge of Medicexchange sales in north, central and south China respectively. Mr. Paul Zheng has also been appointed as Medicexchange's Clinical Applications Manager. He will be responsible for marketing and training of Medicsight CAD software and the construction of frontline hospitals. The new team will be based in Medicexchange's Beijing office and report to Ms. Nancy Zhuang, Sales Director of Medicexchange China.
The newly established sales team will cover all Medicexchange sales and service activities in the China market. Their appointments will help improve Medicexchange's ability to meet customer demands and improve Medicexchange's regional support and response time to its customers and partners. The new sales team will also help drive the company's growth in China.
Mr. David Summer, CEO of Medicsight Asia, said, "To effectively meet the changing demands of our Chinese users, Medicexchange must establish closer contact with our customers. We have now completed our organizational structure in China and the new sales team will cooperate closely with Mr. Gentle Xie, Marketing Director for China, to provide Chinese users with comprehensive marketing, technical and service support."
All three of the new sales managers have rich sales experience:
Mr. Benny Xu, Sales Manager for Central China, was Marketing Director, East China for German company AGFA. He was based in its Shanghai Branch and was responsible for product marketing and the management of its distributors in East China.
Mr. Mercury Liu, Sales Manager for East China, has two years experience in a hospital radiological department and six years experience in product marketing. He was Assistant Manager, North China and Manager, Northwest China for Shimadzu (Hong Kong) Limited.
Mr. Timothy Huang, Sales Manager for South China, served with GE Medical Systems and Philips Medical Systems. He was responsible for product marketing in South China.
Prior to joining Medicexchange, Mr. Paul Zheng, Clinical Applications Manager, worked for GE Medical Systems, CT division as a senior product expert and clinical applications expert. He was responsible for analyzing the CT market, developing product marketing policies, field applications training and cooperative scientific research programs with customers.
About Medicsight Inc
Medicsight, Inc. is the parent company to both Medicsight plc, a leading developer of computer-aided detection (CAD) technologies and software, and operator of Medicexchange.com, an online multi-vendor sales channel for diagnostic, treatment and surgery planning solutions. The CAD technology, which is developed by its subsidiary, Medicsight plc, is tested using one of the world's largest databases of verified CT scan data. Medicsight plc's software solutions help clinicians identify, measure, and analyze suspicious pathology, such as colorectal polyps and lung lesions. The company's CAD products include ColonCAD API, the first CAD technology available for CT colonography, and LungCAD API. Medicsight, Inc.'s subsidiary, Medicexchange.com, is an online multi-vendor sales channel for diagnostic, treatment and surgery planning solutions for cardiac, thoracic, orthopedic, women's and abdominal imaging. Medicexchange.com provides these solutions in a low-cost, on-demand and digitally-downloadable format for medical imaging professionals, providing access to information and products that they would traditionally have difficulty accessing. Headquartered in London, Medicsight, Inc. employs more than 60 people and also has offices in the United States, Japan, and China. Product and company information can be found on www.medicsight.com. Stock symbol: MGT
All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.